Browse CATs

Browse CATs  internal medicine  cardiology  myocardial infarction

Diagnosis Economics Harm/ aetiology Prognosis Therapyv

Chest pain a rapid evaluation unit may save money. Level of evidence 1b- Expiry Date July 2003 Coronary artery disease hypercholesterolaemia: simvastatin therapy is cost-effective Level of evidence 1b Expiry Date March 2003 Coronary heart disease systemic embolism was not very common. Level of evidence 4 Expiry Date March 2003 Ischaemic heart disease Risk stratification affects cost-effectiveness of statin therapy Level of evidence 2b Expiry Date March 2003 Myocardial Infarction captopril was cost-effective. Level of evidence 1b Expiry Date March 2003 Myocardial infarction a nurse-led smoking cessation program was cost-effective. Level of evidence 1b Expiry Date March 2003 Myocardial infarction thrombolytic therapy was cost-effective. Level of evidence 1b Expiry Date March 2003 Myocardial infarction tissue plasminogen activator was cost-effective. Level of evidence 1b Expiry Date March 2003 Myocardial infarction tPA is increasingly cost-effective in older patients. Level of evidence 1b Expiry Date March 2003 Myocardial infarction streptokinase was cost effective. Level of evidence 2b Expiry Date March  2003 Smoking cessation prescribing nicotine patches in general practice was cost effective. Level of evidence 1b Expiry Date March 2003